Latest Deep vein thrombosis Stories
People with asthma have an increased risk of pulmonary embolism, according to new research. A new study, published online ahead of print today (20 December 2012) in the European Respiratory Journal, looked at whether people with moderate or severe asthma had an increased risk of developing deep vein thrombosis, or pulmonary embolism. Pulmonary embolism is when the main artery of the lung or the bronchi becomes blocked. It usually results from deep vein thrombosis; a blood clot in the...
Several studies have linked the newer types of birth control, which contain a man-made hormone known as drospirenone, with a higher risk of potentially fatal blood clots among women. San Antonio, TX (PRWEB) December 16, 2012 Yaz, Yasmin and Ocella injury lawyers today said a study published in the Canadian Medical Association Journal on Dec. 3 raises some alarming concerns about the birth control blood clot risk. According to a Dec. 3, 2012, report in the Reuters about the study, women...
Blau, Brown & Leonard, LLC announce that they have lawyers standing by Toll Free 1-(800) YAZ-0287 if They Took Yaz, Yasmin, BeYaz or Ocella and Suffered Pulmonary Embolisms, DVT's or Stroke; Settlements Continue to Grow New York, NY (PRWEB) December 13, 2012 Sales of Yaz and Yasmin continue to surge according to Bayer's thrid quarter shareholder release. http://www.stockholders-newsletter-q3-2012.bayer.com/en/bayer-healthcare.aspx Blau, Brown & Leonard, LLC settlements...
Studies presented today at the 54th Annual Meeting of the American Society of Hematology (ASH) examine current treatment standards for patients with clotting disorders in an effort to improve outcomes. The studies evaluate long-held treatment standards and whether modifications in intensity and duration of therapy may offer equally effective outcomes while reducing toxicities and relapse rates. Although significant advances have been made in delivering new and improved therapies for...
ATLANTA, Dec. 8, 2012 /PRNewswire-USNewswire/ -- Studies presented today at the 54th( )Annual Meeting of the American Society of Hematology (ASH) examine current treatment standards for patients with clotting disorders in an effort to improve outcomes. The studies evaluate long-held treatment standards and whether modifications in intensity and duration of therapy may offer equally effective outcomes while reducing toxicities and relapse rates. Although significant advances have...
The Drug Risk Resource Center is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com New York, NY (PRWEB) December 07, 2012 The DrugRisk Resource Center, a patient awareness group, is alerting women prescribed the contraceptive NuvaRing that experts have linked the devices to blood clots and the FDA has received thousands of reports of complications among users. According to the Adverse Events Report on...
The Drug Risk Resource Center is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com New York, NY (PRWEB) December 07, 2012 The Drug Risk Resource Center, a patient awareness group, is alerting women prescribed the birth control Yaz or Yasmin that experts have related both the brand name and generic versions of the drugs to risks of blood clots. Bayer recently announced they are settling many of the claims...
The Drug Risk Resource Center is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com Orlando, FL (PRWEB) December 06, 2012 After difficulties earlier this year gaining approval of its cancer treatment ridaforolimus in the United States, drug maker Merck has withdrawn an application for approval of the drug in Europe as well, according to BusinessWeek on November 29, 2012.* The news for Merck comes as...
The Drug Risk Resource Center is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com Dallas, TX (PRWEB) December 06, 2012 The Drug Risk Resource Center, a patient awareness group, is alerting women prescribed the birth control Yaz or Yasmin that experts have related these drugs to blood clots. Also, Bayer recently announced they are continuing to settle certain patient claims. Anyone who suffered a blood...
The Drug Risk Resource Center is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com Miami, FL (PRWEB) December 05, 2012 The DrugRisk Resource Center, a patient awareness group, is alerting women who suffered side effects after using the contraceptive NuvaRing that a judge recently postponed the start of important bellweather trials. U.S. District Judge Rodney Sippel, who will preside over NuvaRing lawsuits...
